BioPharma Patents Quick Tips and News - May/June 2014



35 U.S.C. 112 Tips:

1) Does your U.S. Examiner assert that not enough representative species are described in the specification?

MPEP Section 2163 II.A.3(a)(ii) says that “(t)he written description requirement for a claimed genus may be satisfied through sufficient description of a representative number of species…” Although the word “may” implies that there are other ways to satisfy the requirement, the quoted portion of the MPEP does not specify any. AbbVie v. Janssen Biotech, 2014 WL 2937477 (Fed. Cir. 1 July 2014) helpfully reaffirms that one can also resolve a written description rejection by pointing to a description in the specification of “structural features common to the members of the genus…” (slip op. at 22)

Please see full Newsletter below for more information.

LOADING PDF: If there are any problems, click here to download the file.

DISCLAIMER: Because of the generality of this update, the information provided herein may not be applicable in all situations and should not be acted upon without specific legal advice based on particular situations.

© Harness, Dickey & Pierce, PLC | Attorney Advertising

Written by:


Harness, Dickey & Pierce, PLC on:

Popular Topics
Reporters on Deadline

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:

Sign up to create your digest using LinkedIn*

*By using the service, you signify your acceptance of JD Supra's Privacy Policy.

Already signed up? Log in here

*With LinkedIn, you don't need to create a separate login to manage your free JD Supra account, and we can make suggestions based on your needs and interests. We will not post anything on LinkedIn in your name. Or, sign up using your email address.